Tominaga M - Search Results

1

Evaluating the reported prevalence of type 2 diabetes mellitus by the Oguni diabetes registry using a two-sample method of capture-recapture.

Sekikawa A, Eguchi H, Tominaga M, Manaka H, Sasaki H, Chang YF, Kato T. Sekikawa A, et al. Among authors: tominaga m. Int J Epidemiol. 1999 Jun;28(3):498-501. doi: 10.1093/ije/28.3.498. Int J Epidemiol. 1999. PMID: 10405855

2

Waist to hip ratio, body mass index, and glucose intolerance from Funagata population-based diabetes survey in Japan.

Sekikawa A, Eguchi H, Igarashi K, Tominaga M, Abe T, Fukuyama H, Kato T. Sekikawa A, et al. Among authors: tominaga m. Tohoku J Exp Med. 1999 Sep;189(1):11-20. doi: 10.1620/tjem.189.11. Tohoku J Exp Med. 1999. PMID: 10622204 Free article.

3

Prevalence of diabetes and impaired glucose tolerance in Funagata area, Japan.

Sekikawa A, Tominaga M, Takahashi K, Eguchi H, Igarashi M, Ohnuma H, Sugiyama K, Manaka H, Sasaki H, Fukuyama H, et al. Sekikawa A, et al. Among authors: tominaga m. Diabetes Care. 1993 Apr;16(4):570-4. doi: 10.2337/diacare.16.4.570. Diabetes Care. 1993. PMID: 8462380

4

Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.

Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A. Tominaga M, et al. Diabetes Care. 1999 Jun;22(6):920-4. doi: 10.2337/diacare.22.6.920. Diabetes Care. 1999. PMID: 10372242

5

Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in a rural area of Japan. The Funagata diabetes study.

Sekikawa A, Eguchi H, Tominaga M, Igarashi K, Abe T, Manaka H, Sasaki H, Fukuyama H, Kato T, Kiyohara Y, Fujishima M. Sekikawa A, et al. Among authors: tominaga m. J Diabetes Complications. 2000 Mar-Apr;14(2):78-83. doi: 10.1016/s1056-8727(00)00074-x. J Diabetes Complications. 2000. PMID: 10959069

6

Is examination of fructosamine levels valuable as a diagnostic test for diabetes mellitus?

Sekikawa A, Tominaga M, Takahashi K, Watanabe H, Miyazawa K, Sasaki H. Sekikawa A, et al. Among authors: tominaga m. Diabetes Res Clin Pract. 1990 Mar;8(3):187-92. doi: 10.1016/0168-8227(90)90116-b. Diabetes Res Clin Pract. 1990. PMID: 2340792

7

Genotype Arg/Arg, but not Trp/Arg, of the Trp64Arg polymorphism of the beta(3)-adrenergic receptor is associated with type 2 diabetes and obesity in a large Japanese sample.

Oizumi T, Daimon M, Saitoh T, Kameda W, Yamaguchi H, Ohnuma H, Igarashi M, Eguchi H, Manaka H, Tominaga M, Kato T; Funagata Diabetes Study. Oizumi T, et al. Among authors: tominaga m. Diabetes Care. 2001 Sep;24(9):1579-83. doi: 10.2337/diacare.24.9.1579. Diabetes Care. 2001. PMID: 11522702

8

Insulin-like growth factor I resistance in peripheral tissue but not in liver in streptozotocin-induced diabetic rats.

Tominaga M, Yamatani K, Igarashi M, Eguchi H, Daimon M, Sekikawa A, Sasaki H. Tominaga M, et al. Endocr J. 1995 Jun;42(3):397-403. doi: 10.1507/endocrj.42.397. Endocr J. 1995. PMID: 7670569 Free article.

9

NIDDM with a ceruloplasmin gene mutation.

Daimon M, Yamatani K, Tominaga M, Manaka H, Kato T, Sasaki H. Daimon M, et al. Among authors: tominaga m. Diabetes Care. 1997 Apr;20(4):678. doi: 10.2337/diacare.20.4.678a. Diabetes Care. 1997. PMID: 9097006 No abstract available.

10

Hypersecretion of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide in obese patients.

Fukase N, Igarashi M, Takahashi H, Manaka H, Yamatani K, Daimon M, Tominaga M, Sasaki H. Fukase N, et al. Among authors: tominaga m. Diabet Med. 1993 Jan-Feb;10(1):44-9. doi: 10.1111/j.1464-5491.1993.tb01995.x. Diabet Med. 1993. PMID: 8435987

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,253 results

Search Page

Filters